IDEXX Laboratories' Q2 Comparable Earnings, Revenue Increase; 2026 Outlook Updated

MT Newswires Live08-04

IDEXX Laboratories (IDXX) reported Q2 comparable earnings Tuesday of $4.07 per share, up from $3.53 a year earlier.

Analysts polled by FactSet expected $3.94.

Revenue for the quarter ended June 30 was $1.22 billion, compared with $1.11 billion a year earlier.

Analysts expected $1.20 billion.

The company raised its 2026 EPS guidance to between $14.69 and $14.94, from $14.45 to $14.90 previously. Revenue outlook for the year was narrowed to between $4.70 billion and $4.75 billion, from the previous range of $4.68 billion to $4.76 billion. Analysts expect $14.65 in EPS on revenue of $4.71 billion.

Shares of IDEXX Laboratories were up 1.1% premarket Tuesday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment